QURE compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

QUREuniQure N.V.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

QUREuniQure N.V.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

QUREuniQure N.V.

23.88· pre 22.80· delayed

Mkt cap$1.6BRevenue$5MQ3 FY26Revenue$16MFY25

LLYELI Lilly & Co

1,417.89· pre 1,429.47· delayed

Pre-marketNov 5 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 5 '26delayed

QUREuniQure N.V.

LLYELI Lilly & Co

23.88pre 22.80delayed

Price

1,417.89pre 1,429.47delayed

$1.6B

Mkt cap

$1.3T

Q3 FY26$5M

Revenue

$24.4BQ3 FY26

FY25$16M

Revenue

$65.2BFY25

QURE23.88vsLLY1,417.89Pre-marketNov 5 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

QURE: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only QURE 9

FDMT4D Molecular Therapeuticssupplier

RGNXRegenxbiosupplier

—Apic Biounlistedsupplier

—Cold Spring Harbor Laboratoryunlistedsupplier

5 more · QURE chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

QURE, solidLLY, dashed